Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on October 1, 2026

Oct. 1, 2026

NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier

Indeterminate GlobeNewswire

Oct. 1, 2026

Yesway Completes Iowa and Kansas Portfolio Sale to Redeploy Capital into Higher-Return Growth Opportunities

Indeterminate GlobeNewswire

Oct. 1, 2026

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

Indeterminate GlobeNewswire

Oct. 1, 2026

Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation

Indeterminate GlobeNewswire

Oct. 1, 2026

WISeSat.Space Holdings Corp. Announces Closing of Business Combination with Columbus Acquisition Corp.

Indeterminate GlobeNewswire

Oct. 1, 2026

WISeKey’s Redomiciliation from Switzerland to the British Virgin Islands Becomes Legally Effective

Indeterminate GlobeNewswire

Oct. 1, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Digital Realty Schedules Third Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

Oct. 1, 2026

TFI International to Release Third Quarter 2026 Results

Indeterminate GlobeNewswire

Oct. 1, 2026

TFI International publiera ses résultats du troisième trimestre de 2026

Indeterminate GlobeNewswire

Oct. 1, 2026

Liquidity Services Acquires Invaluable Marketplace

Indeterminate GlobeNewswire

Oct. 1, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

Indeterminate GlobeNewswire

Oct. 1, 2026

Healthy Moms, Healthy Babies America (HMHBA) Announces $20 Million in State Grants for Arkansas and Kentucky

Indeterminate GlobeNewswire

Oct. 1, 2026

Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

Indeterminate GlobeNewswire

Oct. 1, 2026

Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®

Indeterminate GlobeNewswire

Oct. 1, 2026

Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma

Indeterminate GlobeNewswire

Oct. 1, 2026

Das Rennen um SASE-Features ist entschieden. Jetzt beginnt das Rennen um AI Operations

Indeterminate EIN Presswire